Ironwood Pharmaceuticals, Inc.
IRWD
$0.7267
-$0.0233-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.56M | 88.21M | 105.52M | 121.54M | 92.15M |
| Total Receivables | 81.89M | 76.20M | 58.11M | 72.02M | 129.12M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.92M | 14.19M | 14.55M | 14.62M | 12.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 182.37M | 178.60M | 178.18M | 208.17M | 233.29M |
|
|
|||||
| Total Current Assets | 182.37M | 178.60M | 178.18M | 208.17M | 233.29M |
| Net Property, Plant & Equipment | 15.52M | 16.23M | 16.89M | 17.50M | 18.17M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.86M | 3.07M | 3.27M | 3.48M | 3.68M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 150.16M | 191.62M | 197.28M | 209.67M | 215.93M |
| Total Assets | 350.91M | 389.52M | 395.62M | 438.82M | 471.07M |
|
|
|||||
| Total Accounts Payable | 2.13M | 3.24M | 3.23M | 6.22M | 7.83M |
| Total Accrued Expenses | 26.00M | 31.06M | 25.39M | 30.72M | 47.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.19M | 3.17M | 3.16M | 202.94M | 202.69M |
| Total Finance Division Other Current Liabilities | 7.53M | 11.92M | 13.74M | 12.56M | 18.36M |
| Total Other Current Liabilities | 7.53M | 11.92M | 13.74M | 12.56M | 18.36M |
| Total Current Liabilities | 38.85M | 49.38M | 45.51M | 252.44M | 276.10M |
|
|
|||||
| Total Current Liabilities | 38.85M | 49.38M | 45.51M | 252.44M | 276.10M |
| Long-Term Debt | 583.99M | 598.82M | 623.65M | 473.48M | 498.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.30M | 12.88M | 13.45M | 14.00M | 14.54M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.11M | 39.77M | 34.74M | 29.41M | 28.42M |
| Total Liabilities | 652.24M | 700.85M | 717.35M | 769.34M | 817.37M |
|
|
|||||
| Common Stock & APIC | 1.40B | 1.39B | 1.38B | 1.37B | 1.36B |
| Retained Earnings | -1.70B | -1.70B | -1.70B | -1.70B | -1.70B |
| Treasury Stock & Other | 923.00K | -2.05M | -470.00K | -922.00K | -3.03M |
| Total Common Equity | -301.34M | -311.33M | -321.73M | -330.52M | -346.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -301.34M | -311.33M | -321.73M | -330.52M | -346.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -301.34M | -311.33M | -321.73M | -330.52M | -346.30M |
|
|
|||||